跳至主要内容
临床试验/NCT07213115
NCT07213115已完成不适用

Epidemiology and Treatment of Gastric Cancer in the Federal State of Brandenburg From 2000 to 2020. An Analysis Using Data From the Clinical Cancer Registry for Brandenburg and Berlin.

Medizinische Hochschule Brandenburg Theodor Fontane0 个研究点目标入组 8,582 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8,582
主要终点
Overall survival

研究概览

简要总结

According to recent statistics, the incidence and mortality from gastric cancer are both worldwide in fifth place in terms of ranking. Gastric cancer is more common in males than in females. This difference in the incidence between males and females is likely due to the difference in exposure to some risk factors like Helicobacter pylori infection, family history of gastric cancer, dietary habits, smoking and alcohol. However these factors do not completely explain the different characteristics of gastric cancer between the sexes. Some studies have concluded that exposure to estrogen could reduce the risk of gastric cancer.

There is a lack of current population based and real world data on sex and age differences in gastric cancer care. Analyses of sex differences are primarily originate from Asia or focusing on older cohorts. In the Netherlands, Kalff et al. conducted a study with patients with gastric adenocarcinoma (n=2 072) registered in the Dutch Upper GI Cancer Audit between 2011 and 2016. In this study, patients without metastatic gastric cancer and with an elective surgery were included.

To close this sex and age data gap for patients including those with UICC IV stage and without surgery, the aim of our study was to analyze the sex and age differences in clinicopathological features and staging in gastric adenocarcinoma with cancer registry data from the Federal State of Brandenburg from 2000 to 2020.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •gastric adenocarcinomas (ICD-10-GM: C16.0 -C16.9)

排除标准

  • •missing age or sex

结局指标

主要结局

Overall survival

时间窗: 5 year, 10 year

Survival time after date of cancer diagnosis

次要结局

未报告次要终点

研究者

发起方
Medizinische Hochschule Brandenburg Theodor Fontane
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ulrike Weber

MSc.

Medizinische Hochschule Brandenburg Theodor Fontane

相似试验

Epidemiology and Treatment of Gastric Cancer | 临床试验